Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OR4E2 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
mRNA | ADRM1 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
mRNA | CHST6 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
mRNA | CEP170 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
mRNA | CD164 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
mRNA | P2RX2 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
mRNA | SHISA5 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
mRNA | SCGB3A1 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
mRNA | RABEP2 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
mRNA | EBI3 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |